Technical Analysis for GDTC - CytoMed Therapeutics Limited

Grade Last Price % Change Price Change
C 2.77 -1.07% -0.03
GDTC closed down 1.07 percent on Thursday, June 8, 2023, on 4 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -1.07%
NR7 Range Contraction -1.07%
Narrow Range Bar Range Contraction -1.07%
Inside Day Range Contraction -1.07%
Up 3 Days in a Row Strength -1.07%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Resistance about 12 hours ago
Rose Above 20 DMA about 12 hours ago
10 DMA Support about 12 hours ago
Rose Above Previous Day's High about 12 hours ago
Outside Day about 12 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


CytoMed Therapeutics Limited Description

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, which utilizes iPSC as a starting material to generate gdNKT, a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT, a product candidate that consists of expanded gamma delta T cells, and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers. The company was incorporated in 2018 and is headquartered in Singapore. CytoMed Therapeutics Limited operates as a subsidiary of Glorious Finance Ltd


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Immune System Immunotherapy Cancer Treatment Virotherapy Immunotherapies Chimeric Antigen Receptor T Cell Natural Killer Cell Lymphocytes T Cells Human Cancers Pre Clinical Biopharmaceutical

Is GDTC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 4.8
52 Week Low 2.36
Average Volume 146,612
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 2.84
10-Day Moving Average 2.75
Average True Range 0.27
RSI (14) 38.65
ADX 8.84
+DI 13.49
-DI 16.96
Chandelier Exit (Long, 3 ATRs) 3.99
Chandelier Exit (Short, 3 ATRs) 3.17
Upper Bollinger Bands 3.06
Lower Bollinger Band 2.61
Percent B (%b) 0.35
BandWidth 15.89
MACD Line -0.18
MACD Signal Line -0.20
MACD Histogram 0.0239
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.92
Resistance 3 (R3) 2.93 2.89 2.90
Resistance 2 (R2) 2.89 2.85 2.89 2.89
Resistance 1 (R1) 2.83 2.83 2.86 2.82 2.88
Pivot Point 2.79 2.79 2.81 2.79 2.79
Support 1 (S1) 2.73 2.75 2.76 2.72 2.66
Support 2 (S2) 2.69 2.73 2.69 2.65
Support 3 (S3) 2.63 2.69 2.65
Support 4 (S4) 2.62